Image

Recurrent Disease Detection After Resection of Pancreatic Adenocarcinoma Using a Standardized Surveillance Strategy

Monitoring for cancer return after pancreatic surgery using a set plan.

Enrolling By Invitation
18 years and older
All
Phase N/A

This study aims to improve the detection of pancreatic cancer coming back after surgery. Pancreatic ductal adenocarcinoma (PDAC) is a type of cancer that starts in the ducts of the pancreas. After surgery, there's a high chance the cancer might return. The study compares a new, organized plan to watch for cancer, using regular tests and scans, against the usual way, which is not as organized. This new plan uses blood tests (called tumor marker tests) and special X-rays (CT scans) to look for cancer signs every three months for two years after surgery. The goal is to see if this helps people live longer and feel better.

  • Study involves regular testing every 3 months for two years.
  • Participants must have had surgery for pancreatic cancer.
  • Participation requires being part of specific existing studies.
Study details
    Resectable Pancreatic Ductal Adenocarcinoma
    Recurrent Pancreatic Ductal Adenocarcinoma

NCT04875325

UMC Utrecht

31 July 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.